Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2010 / Cilt: 21 - Sayı: 1

Uzun süreli alendronat tedavisi gören hastalarda femoral yetersizlik kırıkları

Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy

Pages
56–59
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However the patient is receiving only calcium and vitamin D.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 76-year-old woman complaining of pain and swelling in her right thigh was admitted to our clinic.
📊
Key Findings & Data:She had been undergoing alendronate therapy for more than 10 years.
💡
Conclusion & Impact:However the patient is receiving only calcium and vitamin D.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 76-year-old woman complaining of pain and swelling in her right thigh was admitted to our clinic. She had been undergoing alendronate therapy for more than 10 years. Physical examination revealed a mild swelling, pathologic motion and pain in her right thigh. Radiograms showed a transverse fracture with a medial spike in the area of thickened cortices of femoral diaphysis. She received surgical stabilization. The patient is now pain-free and she has walked with full weight bearing without any complications since the first postoperative day. Dual-energy X-ray absorptiometry revealed a T-score for the lumbal spine of –2.89 and for the hip of –3.55. We stopped alendronate treatment. However the patient is receiving only calcium and vitamin D.

Özet

On yılı aşkın süredir alendronat kullanmakta olan 76 yaşında bir kadın sağ uyluğunda ağrı ve şişkinlik yakınmasıyla kliniğimize başvurdu. Fizik muayenede hastanın sağ uyluğunda hafif şişkinlik, patolojik hareket ve ağrı saptandı. Röntgen filminde kalınlaşmış femur cismi korteksinde medial kemik çıkıntı ile birlikte transvers kırık görülüyordu. Hastaya cerrahi tespit uygulandı. Ameliyat sonrası birinci günden itibaren tam ağırlık ile komplikasyonsuz olarak yürüyebilen hastada herhangi bir ağrı sorunu olmadı. Çift-enerji X-ışın absorpsiyometri ile T-skoru belde: –2.89, kalçada ise: –3.55 bulundu. Alendronat tedavisi durduruldu. Hasta kalsiyum ve D vitamini almakatadır

🔖

Cite This Article

SULUOVA, F., ALİ, K. A., ATİK, O. Ş., GÖRMELİ, G., YILDIRIM, A. (2022). Uzun süreli alendronat tedavisi gören hastalarda femoral yetersizlik kırıkları. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 21 - Sayı: 1, 56–59. https://ajindex.com/articles/498738

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Atik OS, Uslu MM, Eksioglu F, Satana T. Etiology of senile osteoporosis: a hypothesis. Clin Orthop Relat Res 2006;443:25-7
  2. Atik OS, Gunal I, Korkusuz F. Burden of osteoporosis. Clin Orthop Relat Res 2006;443:19-24
  3. U.S. Food and Drug Administration. Drugs@ FDA. Available from:
  4. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294-301
  5. Lenart BA, Neviaser AS, Lyman S, Chang CC, EdoborOsula F, Steele B, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 2009;20:1353-62
  6. Sayed-Noor AS, Sjödén GO. Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res 2009;467:1921-6
  7. Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg [Am] 2009;91:2556-61
  8. Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg [Br] 2007;89:349-53
  9. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008; 22:346-50
  10. Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf 2009; 32:775-85
  11. Ali T, Jay RH. Spontaneous femoral shaft fracture after long-term alendronate. Age Ageing 2009;38:625-6
  12. Stepan JJ, Burr DB, Pavo I, Sipos A, Michalska D, Li J, et al. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone 2007;41:378-85
  13. Schneider JP. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Geriatrics 2009;64:18-23
  14. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 2008;39:224-31.